Status:
COMPLETED
Use of Aromatherapy to Reduce Symptom Burden
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Indiana University Health
Conditions:
Anxiety
Chemotherapy-induced Nausea and Vomiting
Eligibility:
All Genders
18-100 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effect of inhaled aromatherapy on symptoms of nausea/vomiting and anxiety in patients who have received a stem cell transplant. Aromatherapy involves essen...
Detailed Description
The purpose of this study is to evaluate the efficacy of aromatherapy on symptoms of chemotherapy-induced nausea, vomiting, and retching (CINVR) and anxiety for patients hospitalized for hematopoietic...
Eligibility Criteria
Inclusion
- Patients from a bone marrow transplant unit or hematology/oncology unit within an adult academic health center in the Midwest.
- Adult stem cell transplant inpatients that have received autologous or allogeneic transplant and are actively going through therapy.
- Patients must also be alert and oriented, able to interact with the study team, and able to read and write English.
Exclusion
- Under 18 years of age
- Intubation
- Medical sedation
- Receipt of chimeric antigen receptor T (CAR-T) cells
- History of atrial fibrillation
- History of seizures/epilepsy
- Adhesive allergy or sensitivity
- Currently pregnant
- Prisoner
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2023
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT05251337
Start Date
March 7 2022
End Date
June 22 2023
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Health, University Hospital
Indianapolis, Indiana, United States, 46202